Literature DB >> 31672665

Serial real-time RT-PCR and serology measurements substantially improve Zika and Dengue virus infection classification in a co-circulation area.

Aurelie Gouel-Cheron1, Keith Lumbard2, Sally Hunsberger3, Fernando J Arteaga-Cabello4, John Beigel5, Pablo F Belaunzarán-Zamudio6, Sandra Caballero-Sosa7, Kenia Escobedo-López8, Violeta Ibarra-González9, José Gabriel Nájera-Cancino10, Héctor Armando Rincón-León11, Emilia Ruiz-Hernández12, Jesús Sepúlveda-Delgado13, Karina Trujillo-Murillo14, Guillermo Ruiz-Palacios15.   

Abstract

BACKGROUND: Real-time RT-PCR (Reverse Transcriptase Polymerase Chain Reaction) is considered the gold standard for Zika virus (ZIKV) infection diagnosis, despite its low sensitivity. Diagnosis using recommended serologic cutoffs in co-circulating Flaviviruses areas maybe inadequate due to in-vitro cross-reactivities of Flaviviruses-specific antibodies. We evaluated Zika diagnosis in symptomatic patients using serial RT-PCR and develop a classification model using serial Dengue virus (DENV) and ZIKV serologies.
METHODS: A prospective longitudinal multicentric study in Southern Mexico (NCT02831699) enrolled symptomatic and non-symptomatic participants. In the classification model, true positives were symptomatic (using a modified World Health Organization/Pan American Health Organization definition) with RT-PCR positive for ZIKV or DENV. True negatives were non-symptomatic with negative RT-PCR. Serial serology measurements were used to predict disease status.
RESULTS: Analyzing ZIKV and DENV RT-PCR at 3 timepoints between days 3 and 13 of symptom onset detected 25% more cases than a single RT-PCR analysis between day 0 and 6. When considering sensitivity and specificity together, the serial serology model predicted all categories of disease and negatives better than manufactures cutoffs. Their cutoffs optimized sensitivity or specificity but not both.
CONCLUSIONS: We demonstrated the importance of serial RT-PCR and antibody measurements to diagnose arbovirus infection in symptomatic patients living in regions with co-circulating flaviviruses.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibodies; Dengue virus; Kinetics; Reverse transcriptase polymerase chain reaction; Viremia; Zika virus

Mesh:

Substances:

Year:  2019        PMID: 31672665      PMCID: PMC6901092          DOI: 10.1016/j.antiviral.2019.104638

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  7 in total

1.  Different epidemiological profiles in patients with Zika and dengue infection in Tapachula, Chiapas in Mexico (2016-2018): an observational, prospective cohort study.

Authors:  Pablo F Belaunzarán-Zamudio; Héctor Armando Rincón León; Sandra Caballero Sosa; Emilia Ruiz; José Gabriel Nájera Cancino; Paul Rodriguez de La Rosa; María de Lourdes Guerrero Almeida; John H Powers; John H Beigel; Sally Hunsberger; Karina Trujillo; Pilar Ramos; Fernando J Arteaga-Cabello; Alexander López-Roblero; Raydel Valdés-Salgado; Hugo Arroyo-Figueroa; Eli Becerril; Guillermo Ruiz-Palacios
Journal:  BMC Infect Dis       Date:  2021-08-28       Impact factor: 3.090

Review 2.  The diagnosis of pandemic coronavirus pneumonia: A review of radiology examination and laboratory test.

Authors:  Zhong Zheng; Zhixian Yao; Ke Wu; Junhua Zheng
Journal:  J Clin Virol       Date:  2020-04-29       Impact factor: 3.168

3.  Seroprevalence, spatial dispersion and factors associated with flavivirus and chikungunha infection in a risk area: a population-based seroprevalence study in Brazil.

Authors:  Francisca Kalline de Almeida Barreto; Carlos Henrique Alencar; Fernanda Montenegro de Carvalho Araújo; Rhaquel de Morais Alves Barbosa Oliveira; John Washington Cavalcante; Daniele Rocha Queiroz Lemos; Luís Arthur Brasil Gadelha Farias; Isac Lucca Frota Boriz; Leticia Queiroz Medeiros; Marcelo Nunes Pereira Melo; Fábio Miyajima; André Machado Siqueira; André Ricardo Ribas Freitas; Luciano Pamplona de Góes Cavalcanti
Journal:  BMC Infect Dis       Date:  2020-11-24       Impact factor: 3.090

4.  Comparison of clinical characteristics of Zika and dengue symptomatic infections and other acute illnesses of unidentified origin in Mexico.

Authors:  Pablo F Belaunzarán-Zamudio; Allyson Mateja; Paola Del Carmen Guerra-de-Blas; Héctor A Rincón-León; Karla Navarro-Fuentes; Emilia Ruiz-Hernández; Sandra Caballero-Sosa; Francisco Camas-Durán; Zoila Priego-Smith; José G Nájera-Cancino; Alexander López-Roblero; Karina Del Carmen Trujillo-Murillo; John H Powers; Sally Hunsberger; Sophia Siddiqui; John H Beigel; Raydel Valdés-Salgado; Guillermo Ruiz-Palacios
Journal:  PLoS Negl Trop Dis       Date:  2021-02-16

5.  Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil.

Authors:  Magaly Lima Mota; Robson Dos Santos Souza Marinho; Rodrigo Lopes Sanz Duro; James Hunter; Irwin Rose Alencar de Menezes; João Marcos Ferreira de Lima Silva; Glaubervânio Leite Tavares Pereira; Ester Cerdeira Sabino; Anete Grumach; Ricardo Sobhie Diaz; Maria do Socorro Lucena; Shirley Vasconcelos Komninakis
Journal:  BMC Infect Dis       Date:  2021-07-24       Impact factor: 3.090

6.  Patterns of signs, symptoms, and laboratory values associated with Zika, dengue, and undefined acute illnesses in a dengue endemic region: Secondary analysis of a prospective cohort study in southern Mexico.

Authors:  Sally Hunsberger; Ana M Ortega-Villa; John H Powers; Héctor Armando Rincón León; Sandra Caballero Sosa; Emilia Ruiz Hernández; José Gabriel Nájera Cancino; Martha Nason; Keith Lumbard; Jesús Sepulveda; Paola Del Carmen Guerra de Blas; Guillermo Ruiz-Palacios; Pablo F Belaunzarán-Zamudio
Journal:  Int J Infect Dis       Date:  2020-06-25       Impact factor: 12.074

Review 7.  The diagnosis of SARS-CoV2 pneumonia: A review of laboratory and radiological testing results.

Authors:  Zhong Zheng; Zhixian Yao; Ke Wu; Junhua Zheng
Journal:  J Med Virol       Date:  2020-08-13       Impact factor: 20.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.